TY - CONF
T1 - Embedding of liquids into water soluble materials via additive manufacturing for timed release
AU - Zawaski, Callie
AU - Margaretta, Evan
AU - Stevenson, Andre
AU - Pekkanen, Allison
AU - Whittington, Abby
AU - Long, Timothy
AU - Williams, Christopher B.
N1 - Funding Information: The author would like to thank the Long Lab and Whittington Lab for their collaborative work, Zane Haley for his work on with material properties, Dr. Staley and the Materials Science and Engineering Lab for access to use their machines, equipment, and training, and the Macromolecules Innovation Institute for the continued support and work in setting up collaborative projects, such as this study. Publisher Copyright: Copyright © SFF 2017.All rights reserved. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020
Y1 - 2020
N2 - One fundamental goal of personalized medicine is to provide tailored control of the dissolution rate for an oral dosage pill. Additive manufacturing of oral dose medicine allows for customized dissolution by tailoring both geometric and printed material properties. Direct processing of medicine via filament material extrusion is challenging because many active agents become inactive at the elevated temperatures found in the melt-based process. In this work, this limitation is circumvented by incorporating the active agents via in-situ embedding into a priori designed voids. This concept of embedding active ingredients into printed parts is demonstrated by the in-situ deposition of liquid ingredients into thin-walled, water soluble, printed structures. The authors demonstrate the ability to tune dissolution time by varying the thickness of the printed parts walls using this technique.
AB - One fundamental goal of personalized medicine is to provide tailored control of the dissolution rate for an oral dosage pill. Additive manufacturing of oral dose medicine allows for customized dissolution by tailoring both geometric and printed material properties. Direct processing of medicine via filament material extrusion is challenging because many active agents become inactive at the elevated temperatures found in the melt-based process. In this work, this limitation is circumvented by incorporating the active agents via in-situ embedding into a priori designed voids. This concept of embedding active ingredients into printed parts is demonstrated by the in-situ deposition of liquid ingredients into thin-walled, water soluble, printed structures. The authors demonstrate the ability to tune dissolution time by varying the thickness of the printed parts walls using this technique.
KW - Dissolvable materials
KW - Drug delivery
KW - Embedding
KW - Material extrusion
UR - http://www.scopus.com/inward/record.url?scp=85052472171&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85052472171&partnerID=8YFLogxK
M3 - Paper
SP - 2047
EP - 2059
T2 - 28th Annual International Solid Freeform Fabrication Symposium - An Additive Manufacturing Conference, SFF 2017
Y2 - 7 August 2017 through 9 August 2017
ER -